246 related articles for article (PubMed ID: 29494632)
1. The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system.
Hogwood J; Naggi A; Torri G; Page C; Rigsby P; Mulloy B; Gray E
PLoS One; 2018; 13(3):e0193482. PubMed ID: 29494632
[TBL] [Abstract][Full Text] [Related]
2. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
[TBL] [Abstract][Full Text] [Related]
4. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.
Li B; Suwan J; Martin JG; Zhang F; Zhang Z; Hoppensteadt D; Clark M; Fareed J; Linhardt RJ
Biochem Pharmacol; 2009 Aug; 78(3):292-300. PubMed ID: 19389385
[TBL] [Abstract][Full Text] [Related]
5. Contaminated heparin associated with adverse clinical events and activation of the contact system.
Kishimoto TK; Viswanathan K; Ganguly T; Elankumaran S; Smith S; Pelzer K; Lansing JC; Sriranganathan N; Zhao G; Galcheva-Gargova Z; Al-Hakim A; Bailey GS; Fraser B; Roy S; Rogers-Cotrone T; Buhse L; Whary M; Fox J; Nasr M; Dal Pan GJ; Shriver Z; Langer RS; Venkataraman G; Austen KF; Woodcock J; Sasisekharan R
N Engl J Med; 2008 Jun; 358(23):2457-67. PubMed ID: 18434646
[TBL] [Abstract][Full Text] [Related]
6. Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose- and route-dependent hemodynamic effects in the rat.
Corbier A; Le Berre N; Rampe D; Meng H; Lorenz M; Vicat P; Potdevin S; Doubovetzky M
Toxicol Sci; 2011 Jun; 121(2):417-27. PubMed ID: 21436127
[TBL] [Abstract][Full Text] [Related]
7. Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size.
Li J; Li S; Yan L; Ding T; Linhardt RJ; Yu Y; Liu X; Liu D; Ye X; Chen S
Eur J Med Chem; 2017 Oct; 139():191-200. PubMed ID: 28800457
[TBL] [Abstract][Full Text] [Related]
8. Modulating the degree of fucosylation of fucosylated chondroitin sulfate enhances heparin cofactor II-dependent thrombin inhibition.
Xu L; Gao N; Xiao C; Lin L; Purcell SW; Wu M; Zhao J
Eur J Med Chem; 2018 Jun; 154():133-143. PubMed ID: 29787913
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of thrombin by a fucosylated chondroitin sulfate from echinoderm.
Mourão PA; Boisson-Vidal C; Tapon-Bretaudière J; Drouet B; Bros A; Fischer A
Thromb Res; 2001 Apr; 102(2):167-76. PubMed ID: 11323028
[TBL] [Abstract][Full Text] [Related]
10. Effects of oversulfated and fucosylated chondroitin sulfates on coagulation. Challenges for the study of anticoagulant polysaccharides.
Fonseca RJ; Oliveira SN; Pomin VH; Mecawi AS; Araujo IG; Mourão PA
Thromb Haemost; 2010 May; 103(5):994-1004. PubMed ID: 20352164
[TBL] [Abstract][Full Text] [Related]
11. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
Fonseca RJ; Santos GR; Mourão PA
Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
[TBL] [Abstract][Full Text] [Related]
12. Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm. Sulfated fucose branches on the polysaccharide account for its high anticoagulant action.
Mourão PA; Pereira MS; Pavão MS; Mulloy B; Tollefsen DM; Mowinckel MC; Abildgaard U
J Biol Chem; 1996 Sep; 271(39):23973-84. PubMed ID: 8798631
[TBL] [Abstract][Full Text] [Related]
13. Dermatan sulfate in tunicate phylogeny: order-specific sulfation pattern and the effect of [→4IdoA(2-sulfate)β-1→3GalNAc(4-sulfate)β-1→] motifs in dermatan sulfate on heparin cofactor II activity.
Kozlowski EO; Lima PC; Vicente CP; Lotufo T; Bao X; Sugahara K; Pavão MS
BMC Biochem; 2011 May; 12():29. PubMed ID: 21619699
[TBL] [Abstract][Full Text] [Related]
14. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
[TBL] [Abstract][Full Text] [Related]
15. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D
Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630
[TBL] [Abstract][Full Text] [Related]
16. Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitor.
Zhou ZH; Rajabi M; Chen T; Karnaukhova E; Kozlowski S
PLoS One; 2012; 7(10):e47296. PubMed ID: 23077587
[TBL] [Abstract][Full Text] [Related]
17. Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants.
Mendes A; Meneghetti MCZ; Palladino MV; Justo GZ; Sassaki GL; Fareed J; Lima MA; Nader HB
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426507
[TBL] [Abstract][Full Text] [Related]
18. Sulfation pattern of the fucose branch is important for the anticoagulant and antithrombotic activities of fucosylated chondroitin sulfates.
Chen S; Li G; Wu N; Guo X; Liao N; Ye X; Liu D; Xue C; Chai W
Biochim Biophys Acta; 2013 Apr; 1830(4):3054-66. PubMed ID: 23313164
[TBL] [Abstract][Full Text] [Related]
19. [Anaphylactoid reactions associated with contaminated heparin from China].
Montpas N; Désormeaux A; Keire D; Adam A
Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
[TBL] [Abstract][Full Text] [Related]
20. A nanosensor for ultrasensitive detection of oversulfated chondroitin sulfate contaminant in heparin.
Kalita M; Balivada S; Swarup VP; Mencio C; Raman K; Desai UR; Troyer D; Kuberan B
J Am Chem Soc; 2014 Jan; 136(2):554-7. PubMed ID: 24127748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
